Skip to main content
Clinical Trials/CTRI/2017/06/008750
CTRI/2017/06/008750CompletedPhase 1

A Pharmacotherapeutical study of two source plants of Shalaparni - Desmodium gangeticum DC. and Flemingia strobilifera (L.)W.T. Aiton in Vatarakta

Institute for Post Graduate Teaching and Research in Ayurveda0 sites62 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
62

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients presenting with classical signs and symptoms of purvarupa early symptoms and rupa symptoms of Vatarakta gout
  • Patients having classical signs and symtoms without sandhivaikalya joint deformity

Exclusion Criteria

  • Patients below 18 and above 70 years of age
  • Patients having sandhivaikalya joint deformity and of Gambhira Vatarakta deep seated gout
  • Patients suffering from any systemic diseases like Diabetes Hypertension Cardiac Anomaly Chronic renal failure Liver cirrhosis
  • Pregnant and lactating mother

Investigators

Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda

Similar Trials